Moderna stock rises after analyst upgrade, price target raise

Moderna stock rises after analyst upgrade, price target raise

Yahoo Finance published this video item, entitled “Moderna stock rises after analyst upgrade, price target raise” – below is their description.

#Moderna #yahoofinance #Merck

Yahoo Finance Live anchors Julie Hyman, Brian Sozzi and Brad Smith discuss a Jefferies analyst’s decision to upgrade Moderna stock to Buy.

Yahoo Finance YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

In This Story: Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

CEO: Stéphane Bancel (2011–)

Stock ticker: (NASDAQ:MRNA)

5 Recent Items: Moderna

Major market, sector indices maintain losses ahead of the closing bell

Three-Stock Lunch: MRNA, SCHW & KHC

Moderna’s mRNA RSV vaccine propels stock gains

Moderna CEO on Vaccines, Mutation Risk

December Retail Sales Dip, Earnings Continue, Moderna Trial Results – TheStreet Today LIVE

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.